Abstracts

872 – Mitochondrial DNA Variation and Physical Function Among Men With and Without HIV

Background Mitochondrial DNA variation is associated with multiple aging-related comorbidities among people with HIV (PWH). Data on the effect of inherited mitochondrial DNA variants on physical function among PWH are limited. Methods We included men with ≥2 visits from the Multicenter AIDS Cohort Study. Gait speed and grip strength were evaluated twice annually using standard methods…

858 – Associations Between Antiretroviral Therapy Use, Vitamin C Renal Leak, and Vitamin C Deficiency

Background Reduced vitamin C concentrations (vitC) in HIV are associated with abnormal urinary loss: a renal leak. Renal leak indicates an underlying disease-related nutritional dysregulation independent of dietary intake. While ART use is associated with renal tubular dysfunction, there is insufficient understanding of the relationships between ART class, renal leak and reduced vitC concentrations.  Methods…

911 – Disparities in Hospitalization Among People in the HIV Outpatient Study, United States, 2008-2022

Background Hospitalization rates are an important clinical indicator to monitor treatment effectiveness and the complications of antiretroviral therapy and advanced HIV disease, and provide an endpoint for morbidity among people with HIV (PWH).  We examined sociodemographic and clinical disparities in hospitalization rates among PWH in the HIV Outpatient Study (HOPS), a demographically diverse, multi-city cohort…

859 – Renal Outcomes in People With HIV-1 and Renal Impairment Treated With B/F/TAF in Randomized Trials

Background Chronic kidney disease is common in people with HIV (PWH), with prevalence likely to rise as this population ages. Compared with tenofovir disoproxil fumarate–based antiretroviral regimens, tenofovir alafenamide (TAF)–based regimens have shown a superior renal safety profile, improving treatment options for PWH with renal impairment. Using pooled trial data, we assessed renal outcomes in…

895 – Serum Metabolomic Signatures Associated With InSTI-Related Weight Gain in Women With HIV

Background Initiation of integrase strand-transfer inhibitors (INSTIs) is associated with body weight gain in women with HIV (WWH); however underlying mechanisms are unclear. Leveraging samples from the Women’s Interagency HIV Study (WIHS) cohort, we performed serial high-throughput untargeted metabolomics to determine metabolic signatures associated with INSTI-related weight gain. Methods This study included virologically suppressed (<200…